^
CANCER:

Giant Cell Tumor of Bone

Phase 2
National Cancer Institute (NCI)
Recruiting
Last update posted :
09/22/2021
Initiation :
01/13/2017
Primary completion :
08/01/2022
Completion :
08/01/2022
CD4
|
PD-L1 overexpression • PD-L1 amplification
|
Opdivo (nivolumab) • Yervoy (ipilimumab) • CS1002 (ipilimumab biosimilar) • CMAB 819 (nivolumab biosimilar)
Phase 
Peking University Third Hospital
Completed
Last update posted :
07/07/2021
Initiation :
01/01/2020
Primary completion :
03/01/2020
Completion :
03/01/2020
VEGFA
Phase 2
Novartis Pharmaceuticals
Completed
Last update posted :
01/01/2021
Initiation :
04/23/2012
Primary completion :
12/07/2017
Completion :
12/21/2018
CD14 • CSF1
|
lacnotuzumab (MCS110)
Phase N/A
Istituto Ortopedico Rizzoli
Completed
Last update posted :
07/30/2020
Initiation :
06/05/2019
Primary completion :
12/30/2019
Completion :
06/05/2020
H3F3A
Phase 2
Amgen
Completed
Last update posted :
02/19/2019
Initiation :
09/09/2008
Primary completion :
05/17/2018
Completion :
05/17/2018
ALB
|
Prolia (denosumab)
Phase 3
Hebei Medical University Third Hospital
Recruiting
Last update posted :
08/24/2017
Initiation :
05/01/2016
Primary completion :
05/01/2019
Completion :
05/01/2019
KEAP1 • COL1A1 • GAPDH • TNFRSF11B
|
Prolia (denosumab)
Phase 1
Pediatric Brain Tumor Consortium
Completed
Last update posted :
08/07/2017
Initiation :
08/01/2013
Primary completion :
04/01/2015
Completion :
04/01/2015
ALB
|
TP53 mutation